Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:952-957
Published online before print September 24, 2007, doi: 10.1161/HYPERTENSIONAHA.107.096446
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/5/952    most recent
HYPERTENSIONAHA.107.096446v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, C.
Right arrow Articles by Mehta, J. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, C.
Right arrow Articles by Mehta, J. L
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Receptor pharmacology

(Hypertension. 2007;50:952.)
© 2007 American Heart Association, Inc.


Original Articles

Angiotensin II Induces Capillary Formation From Endothelial Cells Via the LOX-1–Dependent Redox-Sensitive Pathway

Changping Hu; Abhijit Dandapat; Jawahar L Mehta

From the Department of Internal Medicine and Physiology and Biophysics (C.H., A.D., J.L.M.), University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock; and the Department of Pharmacology (C.H.), School of Pharmaceutical Sciences, Central South University, Changsha, China.

Correspondence to Jawahar L. Mehta, Cardiovascular Medicine, University of Arkansas for Medical Sciences, 4301 West Markham St, Slot 532, Little Rock, AR 72205-7199. E-mail MehtaJL{at}uams.edu

Angiotensin II (Ang II) induces angiogenesis by stimulating reactive oxygen species–dependent vascular endothelial growth factor (VEGF) expression. Ang II via type 1 receptor upregulates the expression of LOX-1, a lectin-like receptor for oxidized low-density lipoprotein. LOX-1 activation, in turn, upregulates Ang II type 1 receptor expression. We postulated that interruption of the feedback loop between Ang II and LOX-1 might attenuate Ang II–induced VEGF expression and capillary formation. In vitro experiments showed that Ang II (1 nmol/L) induced the expression of LOX-1 and VEGF and enhanced capillary formation from human coronary endothelial cells in Matrigel assay. Ang II–mediated expression of LOX-1 and VEGF, capillary formation, intracellular reactive oxygen species generation, and phosphorylation of p38 as well as p44/42 mitogen-activated protein kinases, were suppressed by anti–LOX-1 antibody, nicotinamide-adenine dinucleotide phosphate oxidase inhibitor apocynin and the Ang II type 1 receptor blocker losartan, but not by the Ang II type 2 receptor blocker PD123319. Expression of VEGF and capillary formation induced by Ang II were also inhibited by the p44/42 mitogen-activated protein kinase inhibitor U0126 and the p38 mitogen-activated protein kinase inhibitor SB203580. In ex vivo experiments, Ang II stimulated capillary sprouting from aortic rings from wild-type mice, and this phenomenon was significantly attenuated by pretreatment of aortic rings with anti–LOX-1 antibody, apocynin, and losartan, but not by PD123319. Importantly, Ang II–induced capillary sprouting was minimal from aortic rings from LOX-1 null mice compared with wild-type mice. These findings suggest that small concentrations of Ang II promote capillary formation by inducing the expression of VEGF via Ang II type 1 receptor/LOX-1–mediated stimulation of the reactive oxygen species-mitogen-activated protein kinase pathway.


Key Words: angiogenesis • angiotensin • LOX-1 • reactive oxygen species • signaling • vascular endothelial growth factor




This article has been cited by other articles:


Home page
IOVSHome page
Y. Inomata, M. Fukushima, R. Hara, E. Takahashi, M. Honjo, T. Koga, T. Kawaji, H. Satoh, M. Takeya, T. Sawamura, et al.
Suppression of Choroidal Neovascularization in Lectin-like Oxidized Low-Density Lipoprotein Receptor Type 1-Deficient Mice
Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3970 - 3976.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. R. Chade, X. Zhu, R. Lavi, J. D. Krier, S. Pislaru, R. D. Simari, C. Napoli, A. Lerman, and L. O. Lerman
Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular Disease
Circulation, February 3, 2009; 119(4): 547 - 557.
[Abstract] [Full Text] [PDF]